Rhino Sinusitis Recruiting Phase 3 Trials for Cefpodoxime (DB01416)

Also known as: Rhinosinusitis / Rhinosinusitis (disorder) / Highmoritis / Sinusitis (& acute) / Sinusitis / Sinusitis (disorder) / Sinus infection / Sinusitis NOS / Chronic sinusitis

IndicationStatusPhase
DBCOND0087729 (Rhino Sinusitis)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03729258Efficacy and Safety of Modified Release Cefpodoxime Formulation in the Treatment of Acute Sinusitis.Treatment